Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

Tarih
2014
Yazar
Karabulut, Senem
Tas, Faruk
Sen, Fatma
Ciftci, Rumeysa
Duranyildiz, Derya
Disci, Rian
Sakar, Burak
Üst veri
Tüm öğe kaydını göster
Özet
Serum LDH, CEA, and CA19-9 levels are important tumor markers in pancreatic cancer. The purpose of this study was to evaluate the clinical significance of serum LDH, CEA, and CA19-9 levels in metastatic pancreatic cancer (MPC) receiving gemcitabine-based chemotherapy.
Bağlantı
http://hdl.handle.net/20.500.12627/106849
https://doi.org/10.1007/s00280-014-2450-8
Koleksiyonlar